[144] Procter & Gamble Company SEC Filing

Rhea-AI Filing Summary

Procter & Gamble (PG) Form 144 notice: The filer reports a proposed sale of 47,232 shares of Procter & Gamble common stock, with an aggregate market value of $7,316,472.96, to be executed through Morgan Stanley Smith Barney LLC on the NYSE on 08/19/2025. The securities were acquired the prior day, 08/18/2025, as a Performance Stock Program Award from The Procter & Gamble Company, totaling 89,360 shares awarded and paid on 08/18/2025.

The filing states there were 2,342,371,488 shares outstanding at the time of the notice and reports no securities sold by the person in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

• Complete procedural disclosure including broker, exact share count, aggregate value and proposed sale date
• Acquisition and payment details provided: acquisition date 08/18/2025 and nature (Performance Stock Program Award)
• No sales in prior three months reported, simplifying aggregation under Rule 144

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR Form 144 discloses a routine proposed sale of recently awarded shares with full broker and timing details.

The filing provides required mechanics: broker name, exact share count, aggregate market value, proposed sale date, acquisition date and nature (Performance Stock Program Award), and the number of outstanding shares. This level of disclosure aligns with Rule 144 notice requirements and supports market transparency for an insider or affiliated person disposing of restricted or control securities.

Equity Transactions Specialist

TL;DR Transaction appears administrative: sale of a portion of an award one day after grant through an institutional broker.

The notice shows the securities were acquired 08/18/2025 and a sale is proposed for 08/19/2025 via Morgan Stanley Smith Barney. The filer reports no sales in the prior three months, and provides outstanding share count, which allows investors to gauge relative size. There is no additional financial data or indication of material new information about the issuer in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	47232	7316472.96	2342371488	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2025	Performance Stock Program Award	The Procter & Gamble Company			89360	08/18/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Form 144 for PG report?

The notice reports a proposed sale of 47,232 shares of Procter & Gamble common stock.

When is the proposed sale date listed on the PG Form 144?

The proposed sale date is listed as 08/19/2025.

How were the shares being sold acquired according to the filing?

The shares were acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company.

What is the aggregate market value and who is the broker?

Aggregate market value is $7,316,472.96 and the broker is Morgan Stanley Smith Barney LLC.

Does the filing report any securities sold by the person in the past three months?

The filing states Nothing to Report for securities sold during the past three months.